What is the CAGR of the North America EPA and DHA Market between 2026-2031?

The North America EPA and DHA Market is expected to grow at a CAGR of 6.61% between 2026-2031.

Which region is the largest market for the North America EPA and DHA Market?

United States is the largest market for the North America EPA and DHA Market.

Which region is the fastest-growing market for the North America EPA and DHA Market?

Canada is the fastest-growing market for the North America EPA and DHA Market.

Which segment leads the By Product Type category of the North America EPA and DHA Market?

Docosahexaenoic Acid (DHA) leads the By Product Type category of the North America EPA and DHA Market, accounting for approximately 60% share.

New

North America EPA and DHA Market Outlook, 2031

2026

North America EPA and DHA Market Outlook, 2031

North America EPA & DHA Market is segmented into By Product Type (EPA, DHA); By Application (Dietary Supplements, Infant Formula, Pharmaceuticals, Food & Beverages, Clinical Nutrition & Medical Foods, Pet Nutrition); By Source (Fish Oil, Algal Oil, Krill Oil, Other Marine Sources).

Bonafide Research
30-10-2026
Pages : 83
Figures : 11
Tables : 21
Region : North America
Category : Food & Beverages
Food

Schedule a Call
Priyanka Makwana — Research Analyst

Buy Now Get Free sample

The North America EPA and DHA Market is anticipated to grow at more than 6.61% CAGR from 2026 to 2031.

Historical Period2020-2024
Base Year2025
Forecast Period2026-2031
CAGR (2026-2031) 6.61%
Largest MarketUnited States
Fastest Market Canada
Format

Featured Companies

1. Basf SE
2. Chambal Fertilisers
3. Archer-Daniels-Midland Company
4. Omega Protein Corporation
5. Croda International plc
6. Corbion N.V.
More...

Highend Report

Highend report of this product is available

View

New Report Guarantee

If you purchase this report now and we update it in next 100 days, get it free!

EPA and DHA Market Market Market Analysis

North America represents an established market for Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA), supported by consumer awareness of omega-3 fatty acids, a developed dietary supplement industry, and demand for specialised nutritional ingredients. The United States represents an important consumption centre, while Canada and Mexico contribute through dietary supplements, infant nutrition, pharmaceutical formulations, and fortified food products. The regional market is supported by the availability of marine-derived ingredients, established ingredient distribution networks, and growing interest in preventive nutrition. According to the research report, "North America EPA and DHA Market Outlook, 2031," published by Bonafide Research, the North America EPA and DHA Market is anticipated to grow at more than 6.61% CAGR from 2026 to 2031. DHA plays an important role in the regional market because of its applications in infant formula, maternal nutrition, dietary supplements, and specialised nutritional products. Manufacturers incorporate DHA into different formulations to support nutritional requirements associated with brain and visual development. EPA also has established applications in dietary supplements and pharmaceutical formulations, particularly products targeting cardiovascular health and triglyceride management. These applications influence ingredient selection according to concentration, purity, source, formulation requirements, and intended end use. Demand extends beyond conventional dietary supplements into pharmaceuticals, clinical nutrition, medical foods, functional foods and beverages, and pet nutrition. Different applications require specific EPA and DHA concentrations, ingredient formats, oxidation stability, and quality specifications. Consequently, manufacturers evaluate ingredients according to their nutritional composition, processing characteristics, regulatory requirements, and suitability for the intended finished product. The regional market is influenced by increasing awareness of omega-3 consumption, expanding specialised nutrition categories, and product development across supplement and food manufacturing industries. Fish oil remains an established ingredient source because of its availability and established processing infrastructure. Meanwhile, algae oil is attracting attention as an alternative source, particularly for vegetarian and vegan formulations and applications requiring controlled ingredient sourcing. EPA and DHA suppliers operate within a wider value chain involving marine raw material procurement, algae cultivation, oil extraction, refining, concentration, purification, formulation, quality testing, packaging, and distribution. Product stability is an important consideration because these fatty acids are susceptible to oxidation. Manufacturers therefore focus on appropriate processing technologies, antioxidants, encapsulation, and protective packaging to maintain ingredient quality throughout storage and distribution.

to Download this information in a PDF

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

Market Dynamics

Market Drivers•  Growing Awareness of Omega-3 Nutritional Benefits:  Increasing consumer awareness of EPA and DHA is supporting demand for omega-3 dietary supplements and fortified nutritional products across North America. Consumers are incorporating fish oil, krill oil, and algal oil supplements into their daily nutrition routines. According to the National Institutes of Health, EPA and DHA are long-chain omega-3 fatty acids found in seafood and several dietary supplement formats. This awareness supports demand across different consumer groups.
•  Increasing Incorporation of DHA in Infant Formula: DHA is an important ingredient in infant nutrition formulations because of its association with brain and visual development. Infant formula manufacturers incorporate suitable DHA sources into products while considering nutritional composition, ingredient safety, and regulatory requirements. The established infant formula manufacturing industry in North America supports demand for specialised DHA ingredients, including algal-derived oils..

Market Challenges•  Oxidation and Shelf-Life Management:  EPA and DHA contain multiple double bonds, making them susceptible to oxidation during processing, transportation, and storage. Oxidation can affect the sensory characteristics and quality of omega-3 ingredients. Manufacturers must maintain suitable processing conditions and use antioxidants, protective packaging, and controlled storage systems to preserve ingredient stability.
•  Dependence on Marine Raw Material Availability:  Fish oil production depends on the availability of suitable marine resources and the performance of fisheries. Changes in fishing conditions, environmental factors, and seafood processing activities can influence raw material availability and procurement costs. The United States also relies substantially on imported seafood, highlighting the importance of international sourcing and trade networks for marine-derived ingredients.

Market Trends•  Increasing Adoption of Algae-Based Omega-3 Ingredients:  Algae oil is gaining attention as an alternative source of EPA and DHA, particularly in vegetarian and vegan nutritional products. Manufacturers are exploring microalgae cultivation and fermentation technologies to develop controlled-source omega-3 ingredients. Algal oil is particularly relevant for DHA applications, while selected microalgal strains can also provide EPA.
•  Innovation in Omega-3 Delivery Formats:  Manufacturers are expanding beyond conventional fish oil softgels through emulsions, powders, microencapsulated ingredients, gummies, and liquid formulations. These formats address product stability, convenience, taste, and formulation requirements. Such developments are also creating opportunities for EPA and DHA ingredients in functional beverages, fortified foods, and clinical nutrition products.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Priyanka Makwana

Research Analyst

EPA and DHA Market Market Segmentation

By Product Type	Eicosapentaenoic Acid (EPA)
	Docosahexaenoic Acid (DHA)
By Application	Dietary Supplements
	Infant Formula
	Pharmaceuticals
	Food & Beverages
	Clinical Nutrition & Medical Foods
	Pet Nutrition
By Source	Fish Oil
	Algae Oil
	Krill Oil
	Other Marine Sources
North America	United States
	Canada
	Mexico

Docosahexaenoic Acid (DHA) represents the largest product type segment in the North America EPA & DHA Market, supported by its widespread use in infant formula, dietary supplements, maternal nutrition, and specialised nutritional products. Its established role in early-life nutrition and brain and visual development creates demand across the region. The leading position of DHA is supported by its versatility across infant nutrition manufacturers, dietary supplement producers, and functional food companies. Manufacturers incorporate DHA into infant formula to meet specific nutritional requirements, while supplement companies offer DHA-based and combined EPA-DHA formulations for different consumer groups. The United States provides a substantial base of infant formula and dietary supplement manufacturing activity, while Canada and Mexico contribute through their nutritional product industries. Demand is influenced by growing awareness of omega-3 nutritional benefits, maternal nutrition requirements, and the expansion of specialised health products. Algal-derived and fish-derived DHA ingredients serve different formulation and sourcing requirements. These factors support DHA as the largest product type segment in the North American market. Dietary Supplements represent the largest application segment in the North America EPA & DHA Market, supported by their widespread use in omega-3 capsules, softgels, liquid oils, and concentrated nutritional formulations. The established dietary supplement industry and consumer awareness of omega-3 benefits create demand across the region. The leading position of Dietary Supplements is supported by their availability across pharmacies, supermarkets, health stores, and online distribution channels. Manufacturers offer different EPA and DHA concentrations to address general wellness, cardiovascular nutrition, and specialised dietary requirements. The United States provides a substantial consumer base for omega-3 supplements, while Canada and Mexico contribute through expanding health and wellness product distribution. Demand is influenced by preventive healthcare awareness, product innovation, and the availability of fish oil, krill oil, and algae oil formulations. Manufacturers also focus on convenient delivery formats, concentrated ingredients, and improved product quality to attract consumers. These factors support Dietary Supplements as the largest application segment in the North American market. Algae Oil represents the fastest-growing source segment in the North America EPA & DHA Market, supported by increasing demand for alternative omega-3 ingredients, vegetarian nutritional products, and sustainable sourcing options. Its growing applications in dietary supplements and infant nutrition create additional opportunities across the region. The growth of Algae Oil is supported by its suitability as an alternative source of DHA and, depending on the microalgae strain, EPA. Manufacturers are increasingly exploring algal ingredients for vegetarian and vegan omega-3 supplements, infant formula, and specialised nutritional formulations. The United States provides opportunities through its established nutritional ingredient and biotechnology industries, while Canada and Mexico offer additional opportunities through dietary supplement and functional nutrition markets. Demand is influenced by consumer interest in plant-based nutritional alternatives, ingredient traceability, and reduced dependence on conventional marine raw materials. Improvements in microalgae cultivation, fermentation, extraction, and processing technologies are also helping manufacturers improve production efficiency and ingredient consistency. These factors support Algae Oil as the fastest-growing source segment in the North American market.

to Download this information in a PDF

EPA and DHA Market Market Market Regional Insights

The United States represents the largest market for EPA and DHA in North America, supported by its well-established dietary supplement industry, extensive pharmaceutical sector, infant nutrition manufacturing base, and growing demand for specialised nutritional products. Its developed healthcare infrastructure and established distribution networks create substantial demand for omega-3 ingredients across multiple applications. The leading position of the United States is supported by widespread consumption of omega-3 dietary supplements and the presence of established manufacturers supplying EPA and DHA ingredients to food, pharmaceutical, and nutritional product companies. Demand is influenced by increasing awareness of cardiovascular health, infant nutrition requirements, preventive healthcare, and specialised dietary products. The country also benefits from established ingredient sourcing and distribution networks, connecting domestic manufacturers with international fish oil, krill oil, and algae oil suppliers. Growing interest in concentrated EPA formulations, algal DHA ingredients, functional foods, and premium pet nutrition products further supports market development. These factors reinforce the United States as the largest country market for EPA and DHA in North America.

to Download this information in a PDF

Don't pay for what you don't need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

Companies Mentioned

Basf SE
Chambal Fertilisers
Archer-Daniels-Midland Company
Omega Protein Corporation
Croda International plc
Corbion N.V.
Nissui Corporation
DSM-Firmenich AG
Connoils LLC
Bioriginal Food & Science Corp

1. Executive Summary
2. Market Dynamics
2.1. Market Drivers & Opportunities
2.2. Market Restraints & Challenges
2.3. Market Trends
2.4. Supply chain Analysis
2.5. Policy & Regulatory Framework
2.6. Industry Experts Views
3. Research Methodology
3.1. Secondary Research
3.2. Primary Data Collection
3.3. Market Formation & Validation
3.4. Report Writing, Quality Check & Delivery
4. Market Structure
4.1. Market Considerate
4.2. Assumptions
4.3. Limitations
4.4. Abbreviations
4.5. Sources
4.6. Definitions
5. Economic /Demographic Snapshot
6. North America EPA and DHA Market Outlook
6.1. Market Size By Value
6.2. Market Share By Country
6.3. Market Size and Forecast, By Product Type
6.4. Market Size and Forecast, By Application
6.5. Market Size and Forecast, By Source
6.6. United States EPA and DHA Market Outlook
6.6.1. Market Size by Value
6.6.2. Market Size and Forecast By Product Type
6.6.3. Market Size and Forecast By Application
6.6.4. Market Size and Forecast By Source
6.7. Canada EPA and DHA Market Outlook
6.7.1. Market Size by Value
6.7.2. Market Size and Forecast By Product Type
6.7.3. Market Size and Forecast By Application
6.7.4. Market Size and Forecast By Source
6.8. Mexico EPA and DHA Market Outlook
6.8.1. Market Size by Value
6.8.2. Market Size and Forecast By Product Type
6.8.3. Market Size and Forecast By Application
6.8.4. Market Size and Forecast By Source
7. Competitive Landscape
7.1. Competitive Dashboard
7.2. Business Strategies Adopted by Key Players
7.3. Key Players Market Positioning Matrix
7.4. Porter's Five Forces
7.5. Company Profile
7.5.1. DSM-Firmenich AG
7.5.1.1. Company Snapshot
7.5.1.2. Company Overview
7.5.1.3. Financial Highlights
7.5.1.4. Geographic Insights
7.5.1.5. Business Segment & Performance
7.5.1.6. Product Portfolio
7.5.1.7. Key Executives
7.5.1.8. Strategic Moves & Developments
7.5.2. BASF SE
7.5.3. Croda International plc
7.5.4. KD Pharma Group
7.5.5. Corbion N.V.
7.5.6. Archer-Daniels-Midland Company
7.5.7. Omega Protein Corporation
7.5.8. Nissui Corporation
7.5.9. Bioriginal Food & Science Corp.
7.5.10. Connoils LLC
8. Strategic Recommendations
9. Annexure
9.1. FAQ`s
9.2. Notes
10. Disclaimer

Table 1: Influencing Factors for EPA and DHA Market, 2025
Table 2: Top 10 Counties Economic Snapshot 2024
Table 3: Economic Snapshot of Other Prominent Countries 2022
Table 4: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 5: North America EPA and DHA Market Size and Forecast, By Product Type (2025 to 2031F) (In USD Billion)
Table 6: North America EPA and DHA Market Size and Forecast, By Application (2025 to 2031F) (In USD Billion)
Table 7: North America EPA and DHA Market Size and Forecast, By Source (2025 to 2031F) (In USD Billion)
Table 8: United States EPA and DHA Market Size and Forecast By Product Type (2025 to 2031F) (In USD Billion)
Table 9: United States EPA and DHA Market Size and Forecast By Application (2025 to 2031F) (In USD Billion)
Table 10: United States EPA and DHA Market Size and Forecast By Source (2025 to 2031F) (In USD Billion)
Table 11: Canada EPA and DHA Market Size and Forecast By Product Type (2025 to 2031F) (In USD Billion)
Table 12: Canada EPA and DHA Market Size and Forecast By Application (2025 to 2031F) (In USD Billion)
Table 13: Canada EPA and DHA Market Size and Forecast By Source (2025 to 2031F) (In USD Billion)
Table 14: Mexico EPA and DHA Market Size and Forecast By Product Type (2025 to 2031F) (In USD Billion)
Table 15: Mexico EPA and DHA Market Size and Forecast By Application (2025 to 2031F) (In USD Billion)
Table 16: Mexico EPA and DHA Market Size and Forecast By Source (2025 to 2031F) (In USD Billion)
Table 17: Competitive Dashboard of top 5 players, 2025

Figure 1: North America EPA and DHA Market Size By Value (2025, 2025 & 2031F) (in USD Billion)
Figure 2: North America EPA and DHA Market Share By Country (2025)
Figure 3: United States EPA and DHA Market Size By Value (2025, 2025 & 2031F) (in USD Billion)
Figure 4: Canada EPA and DHA Market Size By Value (2025, 2025 & 2031F) (in USD Billion)
Figure 5: Mexico EPA and DHA Market Size By Value (2025, 2025 & 2031F) (in USD Billion)
Figure 6: Porter's Five Forces of Global EPA and DHA Market

EPA and DHA Market Market Market Research FAQs

The North America EPA & DHA Market includes omega-3 ingredients used in dietary supplements, infant formula, pharmaceuticals, food and beverages, clinical nutrition, medical foods, and pet nutrition. Demand is influenced by growing awareness of omega-3 nutritional benefits, expansion of specialised nutrition products, and increasing applications across healthcare and food industries.

Docosahexaenoic Acid (DHA) represents the largest product type segment, supported by its extensive applications in infant formula, dietary supplements, maternal nutrition, and specialised nutritional products.

Dietary Supplements represent the largest application segment, driven by established consumer demand for omega-3 capsules, softgels, liquid oils, and concentrated nutritional formulations.

Algae Oil is expected to be the fastest-growing source segment, supported by increasing demand for alternative omega-3 ingredients, vegetarian supplements, and specialised DHA formulations.

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted